Paper Details

  1. Home
  2. Paper Details

Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.

Author: BarGali, BlanaruMonica, GorelikIelena, Heresco-LevyUriel, JavittDaniel C, KremerIlana, VassAgnes

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Lamotrigine is a drug used to treat seizures, but it may also help to improve mood and thinking skills in people with bipolar disorder and schizophrenia.
Paper Details　
Original Abstract of the Article :
Lamotrigine, a novel anticonvulsant drug having modulatory effects on glutamatergic neurotransmission, improves mood and cognition parameters in bipolar disorder. Recent studies suggest that when added to clozapine, lamotrigine treatment may result in significant positive symptoms reductions in schi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15364042

データ提供：米国国立医学図書館（NLM）

Lamotrigine: A Promising Adjunct for Schizophrenia Treatment?

The world of mental health research is always striving to find new ways to manage complex conditions like schizophrenia. This study delves into the potential benefits of lamotrigine, an anticonvulsant medication, as an additional treatment for schizophrenia when combined with conventional and atypical antipsychotics. The researchers used a placebo-controlled trial to investigate the effects of lamotrigine on patients with schizophrenia, focusing on its impact on mood and cognitive function. Their findings suggest that lamotrigine might hold promise as a potential treatment option, particularly when used alongside clozapine, a specific type of antipsychotic.

Lamotrigine: A Hopeful Sign for Schizophrenia Treatment

This study sheds light on the potential of lamotrigine to improve the lives of people with schizophrenia. It demonstrates that lamotrigine, when combined with clozapine, can lead to a significant reduction in positive symptoms. This discovery is particularly encouraging as there is a constant need for more effective treatment strategies for this challenging illness.

Navigating the Landscape of Schizophrenia Treatment

It's crucial to remember that this research is still in its early stages. More extensive research is needed to confirm these findings and establish the long-term effects of lamotrigine. If you're living with schizophrenia or know someone who is, remember to consult with your doctor or mental health professional for personalized guidance and treatment options. Schizophrenia treatment is a multifaceted journey, and finding the right combination of therapies is key to managing the condition effectively.

Dr.Camel's Conclusion

This research is like finding a hidden oasis in the vast desert of schizophrenia treatment. While we need to explore this new path carefully, lamotrigine may offer a ray of hope for individuals struggling with this complex disorder.

Date :
  1. Date Completed 2004-11-08
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

15364042

DOI: Digital Object Identifier

S0006-3223(04)00707-3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.